215 related articles for article (PubMed ID: 36660885)
21. Long-term efficacy and complications of a multicentre randomised controlled trial comparing retropubic and transobturator mid-urethral slings: a prospective observational study.
Offiah I; Freeman R;
BJOG; 2021 Dec; 128(13):2191-2199. PubMed ID: 34478604
[TBL] [Abstract][Full Text] [Related]
22. Impact of the availability of midurethral slings on treatment strategies for stress urinary incontinence: a cost-effectiveness analysis.
Chang OH; Cadish LA; Kailasam A; Ridgeway BM; Shepherd JP
BJOG; 2022 Feb; 129(3):500-508. PubMed ID: 34314554
[TBL] [Abstract][Full Text] [Related]
23. Comparison of retropubic synthetic mid-urethral slings to fascia pubovaginal slings following failed sling surgery.
Aberger M; Gomelsky A; Padmanabhan P
Neurourol Urodyn; 2016 Sep; 35(7):851-4. PubMed ID: 26175333
[TBL] [Abstract][Full Text] [Related]
24. Outcomes and failure risks in mid-urethral sling insertion in elderly and old age with urodynamic stress incontinence.
Lo TS; Shailaja N; Tan YL; Wu MP; Chua S; Roy KW
Int Urogynecol J; 2020 Apr; 31(4):717-726. PubMed ID: 31832716
[TBL] [Abstract][Full Text] [Related]
25. Comparison of an adjustable anchored single-incision mini-sling, Ajust(®) , with a standard mid-urethral sling, TVT-O(TM) : a health economic evaluation.
Boyers D; Kilonzo M; Mostafa A; Abdel-Fattah M
BJU Int; 2013 Dec; 112(8):1169-77. PubMed ID: 24053310
[TBL] [Abstract][Full Text] [Related]
26. A randomized comparison of a single-incision needleless (Contasure-needleless®) mini-sling versus an inside-out transobturator (Contasure-KIM®) mid-urethral sling in women with stress urinary incontinence: 24-month follow-up results.
Dogan O; Kaya AE; Pulatoglu C; Basbug A; Yassa M
Int Urogynecol J; 2018 Sep; 29(9):1387-1395. PubMed ID: 29549394
[TBL] [Abstract][Full Text] [Related]
27. Comparing Single-Incision Midurethral Sling with Bulking Agents for Female Stress Urinary Incontinence: Rationale for a Non-Randomized Controlled Trial.
Osse NJE; Schonewille MEA; Engberts MK; Blanker MH; Klerkx WM; van Eijndhoven HWF
Gynecol Obstet Invest; 2023; 88(2):123-131. PubMed ID: 36716732
[TBL] [Abstract][Full Text] [Related]
28. "Mesh free" autologous transobturator mid urethral sling placement for predominant stress urinary incontinence: A pilot study.
Vasudeva P; Tyagi V; Kumar N; Yadav S; Prasad V; Iyer SG
Neurourol Urodyn; 2021 Feb; 40(2):659-665. PubMed ID: 33348447
[TBL] [Abstract][Full Text] [Related]
29. Outpatient mid-urethral tissue fixation system sling for urodynamic stress urinary incontinence: 3-year surgical and quality of life results.
Nakamura R; Yao M; Maeda Y; Fujisaki A; Sekiguchi Y
Int Urogynecol J; 2017 Nov; 28(11):1733-1738. PubMed ID: 28500515
[TBL] [Abstract][Full Text] [Related]
30. Cost-Utility Analysis of Midurethral Sling Timing Among Women Undergoing Prolapse Surgery.
Sassani JC; Giugale LE; Lavelle ES; Shepherd JP
Urogynecology (Phila); 2024 Jan; 30(1):65-72. PubMed ID: 37493280
[TBL] [Abstract][Full Text] [Related]
31. Reoperation rates for stress urinary incontinence and pelvic organ prolapse in women after undergoing Mid-Urethral sling with or without concomitant colporrhaphy in academic centers within the United States.
Kim P; Cantrell AB; Wallach SJ; Rothschild J; Durbin-Johnson B; Kurzrock EA
J Obstet Gynaecol; 2022 Aug; 42(6):2381-2386. PubMed ID: 35712775
[TBL] [Abstract][Full Text] [Related]
32. Sexual Functions in Women With Stress Urinary Incontinence After Mid-Urethral Sling Surgery: A Systematic Review and Meta-Analysis of Prospective Randomized and Non-Randomized Studies.
Lai S; Diao T; Zhang W; Seery S; Zhang Z; Hu M; Meng L; Ma T; Liu X; Wang J; Zhang Y
J Sex Med; 2020 Oct; 17(10):1956-1970. PubMed ID: 32741744
[TBL] [Abstract][Full Text] [Related]
33. Bulking agents for the treatment of recurrent stress urinary incontinence: a suitable option?
Serati M; Giammò A; Carone R; Ammirati E; Gubbiotti M; Ruffolo A; Salvatore S; Scancarello C; Castronovo F; Caccia G; Braga A;
Minerva Urol Nephrol; 2022 Dec; 74(6):747-754. PubMed ID: 33949184
[TBL] [Abstract][Full Text] [Related]
34. 2021 opinion from the CUROPF on THE efficacy and safety of mid-urethral slings used in women WITH urinary stress incontinence.
Cardot V; Campagne-Loiseau S; Roulette P; Peyrat L; Vidart A; Wagner L; Thuillier C; Klap J; Hurel S; Hermieu JF; Girard F; Even L; Donon L; Charles T; Tibi B; Bosset PO; Berrogain N; Meyer F; Cornu JN; Deffieux X
Prog Urol; 2022 Mar; 32(4):247-257. PubMed ID: 34920924
[TBL] [Abstract][Full Text] [Related]
35. A cost-effectiveness analysis of conservative versus surgical management for the initial treatment of stress urinary incontinence.
Richardson ML; Sokol ER
Am J Obstet Gynecol; 2014 Nov; 211(5):565.e1-6. PubMed ID: 25019485
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of the surgical treatment of female urinary incontinence using slings and meshes.
Montesino-Semper MF; Jimenez-Calvo JM; Cabases JM; Sanchez-Iriso E; Hualde-Alfaro A; García-García D
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):180-6. PubMed ID: 24035322
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy Report for the Use of Poly-4-Hydroxybutyrate as a Retropubic Mid-Urethral Sling (MUS) for Stress Urinary Incontinence: A Prospective 24 Months Follow-Up of New Poly-4-Hydroxybutyrate TephaFlex SUI Bioresorbable MUS.
van Rest KLC; Kastelein AW; Brouard KJ; Ras L; Jeffery ST; Roovers JWR
J Minim Invasive Gynecol; 2024 Feb; 31(2):131-137. PubMed ID: 37984515
[TBL] [Abstract][Full Text] [Related]
38. How cure rates drive patients' preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence.
Casteleijn FM; Enklaar RA; El Bouyahyaoui I; Jeffery S; Zwolsman SE; Roovers JWR
Neurourol Urodyn; 2019 Jun; 38(5):1384-1391. PubMed ID: 30989703
[TBL] [Abstract][Full Text] [Related]
39. Repeat midurethral sling compared with urethral bulking for recurrent stress urinary incontinence.
Gaddi A; Guaderrama N; Bassiouni N; Bebchuk J; Whitcomb EL
Obstet Gynecol; 2014 Jun; 123(6):1207-1212. PubMed ID: 24807335
[TBL] [Abstract][Full Text] [Related]
40. Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up.
Braga A; Castronovo F; Ottone A; Torella M; Salvatore S; Ruffolo AF; Frigerio M; Scancarello C; De Rosa A; Ghezzi F; Papadia A; Caccia G; Serati M
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
